937 Post-immunotherapy survivorship in advanced melanoma (aMEL): routine versus symptom-based imaging surveillance, a retrospective review in a large integrated healthcare network, Kaiser Permanente Northern California (KPNC)

BackgroundBest practice in surveillance imaging for survivors after immune checkpoint inhibitors (CPI) remain poorly defined for stage 3-4 aMEL; KPNC oversees care for 4 million patients and has 300 new diagnoses of aMEL per year. Follow-up after CPI is coordinated in KPNC via care pathways using na...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal for immunotherapy of cancer 2022-11, Vol.10 (Suppl 2), p.A980-A980
Hauptverfasser:	Kavecansky, Juraj, Xu, Richie, Lue-Yen Tucker, Tavakoli, Jahan, Menter, Alexander, Truong, Thach-Giao
Format:	Artikel
Sprache:	eng
Schlagworte:	Asymptomatic Breast cancer Immunotherapy Melanoma Mortality Surveillance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!